Drug intelligence / Profile preview

Relinqing granules

Development stage
Unknown
Lead developer
Guizhou Warmen Pharmaceutical
Administration
Oral
01

Overview

**Relinqing granules** are an orally administered Chinese patent herbal medicine manufactured by Guizhou Warmen Pharmaceutical. The product is a single-herb preparation derived from *Polygonum capitatum* Buch.-Ham. ex D. Don, known in Chinese as 头花蓼. It is approved in China for traditional-medicine syndromes of lower-jiao damp-heat presenting as urinary frequency, urgency, and dysuria, including urinary tract infection and pyelonephritis with the corresponding syndrome pattern. The labeled pharmacological rationale is heat-clearing and promotion of urination; experimental literature describes antimicrobial, anti-inflammatory, diuretic, and analgesic activities, but no single validated molecular target or target-specific mechanism has been established for the chemically complex botanical preparation. ([warmen.com](https://www.warmen.com/product/217.html))

Brand names
RelinqingWeimen
Other names
热淋清颗粒Relinqing KeliRelinqing granuleRLQ
02

Targets

ABCB1 (P-glycoprotein)

Beyond the preview

Go deeper on Relinqing granules.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Relinqing granules.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call